# K131952: Corin Metafix Hip Stem - Pathway: 510(k) (Traditional) - Applicant: Corin USA - Decided: Dec 16, 2013 after 172 days - Product code: LZO (Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented) - Device class: 2 - Regulation: 21 CFR 888.3353 - Recalls of this device: none - Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026 ## Lineage Longest line of descent: 15 generations back to K810258 (1981). 123 ancestors in all. 4 later devices descend from it; 1 cites it directly. 0 of 127 devices in its family (counting itself) have a Class I recall. ## Predicates on the family tree (from the FDA summary) - K082525: Corin Metafix Femoral Stem, Corin USA (2010) Summary page 2. - K121439: Metafix Femoral Hip Stem Size 1, Corin USA (2012) Summary page 2. - K120362: Metafix Femoral Stem for Hemi-Arthroplasty, Corin USA (2012) Summary page 2. - K130634: Corin Metafix Hip Stem, Corin USA (2013) Summary page 2. - K130343: Corin Trinity Acetabular System with Extra-Long Heads, Corin USA (2013) Summary page 2. ## Most influential descendants - K162942: Corin MetaFix Hip Stem (2017), 3 descendants of its own - K212069: Corin MetaFix™ Hip Stem (2022), 2 descendants of its own - K241472: Icona Hip Stem (2024), 1 descendant of its own - K261576: Icona Hip Stem (2026), 0 descendants of its own ## Indications for use The indications for the Corin Metafix Hip Stem as a total hip arthroplasty and, when used in combination with Corin hemi-arthroplasty femoral heads, as a hemi-arthroplasty, include: * Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis * Rheumatoid arthritis * Correction of functional deformity * Treatment of non-union, femoral neck and trochanteric fractures of the proximal femur * Developmental dysplasia of the hip (DDH) and congenital dysplasia of the hip (CDH) The Corin Metafix Hip Stem is indicated for cementless use only. Source page: https://510kreport.com/device/K131952 Methodology: https://510kreport.com/methodology